Item Type: | Article |
---|---|
Title: | 2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors |
Creators Name: | Simon, T. and Hero, B. and Schulte, J.H. and Deubzer, H. and Hundsdoerfer, P. and von Schweinitz, D. and Fuchs, J. and Schmidt, M. and Prasad, V. and Krug, B. and Timmermann, B. and Leuschner, I. and Fischer, M. and Langer, T. and Astrahantseff, K. and Berthold, F. and Lode, H. and Eggert, A. |
Abstract: | The clinical course of neuroblastoma is more heterogeneous than any other malignant disease. Most low-risk patients experience regression after limited or even no chemotherapy. However, more than half of high-risk patients die from disease despite intensive multimodal treatment. Precise patient characterization at diagnosis is key for risk-adapted treatment. The guidelines presented here incorporate results from national and international clinical trials to produce recommendations for diagnosing and treating neuroblastoma patients in German hospitals outside of clinical trials. |
Keywords: | Neuroblastoma, Ganglioneuroma, Childhood Cancer, Treatment Recommendations |
Source: | Klinische Padiatrie |
ISSN: | 0300-8630 |
Volume: | 229 |
Number: | 3 |
Page Range: | 147-167 |
Date: | May 2017 |
Official Publication: | https://doi.org/10.1055/s-0043-103086 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page